CLINICAL_TRIALS
ClinicalTrials.gov record update
Multiple Consolidation Chemotherapy and DLI Prevent Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant and Achieving Complete Remission After Induction Chemotherapy and DLI
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03297528
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:47.529900+00:00
- Published At
- 2020-03-10T00:00:00+00:00
- Record Updated At
- 2020-03-10
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Donor Lymphocyte Infusion", "Allogeneic Hematopoietic Stem Cell Transplantation", "Acute Leukemia", "Minimal Residual Disease", "Graft-versus-host Disease", "Relapse"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-03-10"- protocolSection.identificationModule.nctId
"NCT03297528"- protocolSection.identificationModule.officialTitle
"Multiple Consolidation Chemotherapy and DLI Prevent Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant and Achieving Complete Remission After Induction Chemotherapy and DLI"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.